Alphabet Inc. Verve Therapeutics, Inc. Transaction History
Alphabet Inc.
- $1.12 Billion
- Q1 2025
A detailed history of Alphabet Inc. transactions in Verve Therapeutics, Inc. stock. As of the latest transaction made, Alphabet Inc. holds 12,349,086 shares of VERV stock, worth $137 Million. This represents 5.03% of its overall portfolio holdings.
Number of Shares
12,349,086
Previous 12,349,086
-0.0%
Holding current value
$137 Million
Previous $69.6 Million
18.97%
% of portfolio
5.03%
Previous 4.92%
Shares
3 transactions
Others Institutions Holding VERV
# of Institutions
203Shares Held
79.5MCall Options Held
204KPut Options Held
101K-
Bvf Inc San Francisco, CA6.9MShares$76.7 Million1.39% of portfolio
-
Black Rock Inc. New York, NY6.62MShares$73.5 Million0.0% of portfolio
-
Casdin Capital, LLC New York, NY4MShares$44.4 Million2.14% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.96MShares$43.9 Million0.0% of portfolio
-
State Street Corp Boston, MA3.09MShares$34.3 Million0.0% of portfolio
About Verve Therapeutics, Inc.
- Ticker VERV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,942,300
- Market Cap $666M
- Description
- Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program t...